FrancophonIA/ELRC3.0 huggingface dataset:
English: Perform a one-handed technique by GENTLY pressing the sheath against a flat surface.
Croatian: Koristeći jednu ruku NJEŽNO pritisnite pokrov na ravnu površinu.
English: Olanzapine-treated patients had a lower incidence of Parkinsonism, akathisia and dystonia compared with titrated doses of haloperidol.
Croatian: Bolesnici liječeni olanzapinom imali su nižu incidenciju parkinsonizma, akatizije i distonije u usporedbi s bolesnicima na titriranim dozama haloperidola.
English: A lower starting dose (150 mg/4 weeks) is not routinely indicated, but should be considered for those 65 and over when clinical factors warrant.
Croatian: (150 mg/4 tjedna) nije rutinski indicirana, treba je uzeti u obzir u bolesnika u dobi od 65 i više godina ako to zahtijevaju klinički čimbenici.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 19/11/2008
Croatian: Datum prvog odobrenja: 19.11.2008.
English: Tel: + 371 67364000
Croatian: Tel: + 371 67364000 Lietuva
English: The following symptoms may occur in newborn babies, of mothers that have used ZYPAHDERA in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
Croatian: Ako majka koristi lijek ZYPADHERA u zadnjem tromjesečju (zadnja tri mjeseca trudnoće) kod novorođenčadi se mogu pojaviti sljedeći simptomi: trzaji (drhtanje), ukočenost mišića i/ili slabost, pospanost, uznemirenost, tegobe s disanjem te poteškoće pri hranjenju.
English: • difficulty talking
Croatian: • otežan govor
English: A causal relationship between the occurrence of venous thromboembolism and treatment with olanzapine has not been established.
Croatian: Nije utvrđena uzročno posljedična povezanost između pojave venske tromboembolije i liječenja olanzapinom.
English: The pharmacokinetic variability observed in the elderly is within the range for the non-elderly.
Croatian: Varijabilnost farmakokinetike u starijih bolesnika je u istom rasponu kao u mlađih bolesnika.
English: Clinical signs included sedation, ataxia, tremors, increased heart rate, laboured respiration, miosis, and anorexia.
Croatian: Klinički znakovi uključivali su sedaciju, ataksiju, tremor, ubrzani rad srca, teško disanje, miozu i anoreksiju.
English: This table confirms the final ZYPADHERA suspension volume to inject.
Croatian: Sljedeća tablica prikazuje konačni volumen suspenzije lijeka ZYPADHERA koji se daje u injekciji.
English: If an overdose is suspected, close medical supervision and monitoring should continue until examination indicates that signs and symptoms have resolved (see section 4.4.).
Croatian: Ako se posumnja na predoziranje, mora se nastaviti pojačan medicinski nadzor i praćenje takvih bolesnika sve dok se pregledom ne ustanovi da su se znakovi i simptomi povukli (vidjeti dio 4.4).
English: In renally impaired patients (creatinine clearance < 10 ml/min) versus healthy subjects, there was no significant difference in mean elimination half-life (37.7 versus 32.4 hours) or clearance (21.2 versus 25.0 l/hr).
Croatian: U bolesnika s oštećenom funkcijom bubrega (klirens kreatinina < 10 ml/min) nije bilo značajne razlike u srednjoj vrijednosti poluvremena eliminacije (37,7 naspram 32,4 sati) niti klirensu (21,2 naspram 25,0 l/h) u odnosu na zdrave ispitanike.
English: However, caution should be exercised when olanzapine is prescribed with medicines known to increase QTc interval, especially in the elderly, in patients with congenital long QT syndrome, congestive heart failure, heart hypertrophy, hypokalaemia or hypomagnesaemia.
Croatian: Unatoč tome, mora se s oprezom istodobno propisivati olanzapin s lijekovima koji produljuju QTc-interval, posebice u starijih bolesnika, u bolesnika s prirođenim sindromom produljenog QT intervala, kongestivnim zatajenjem srca, srčanom hipertrofijom, hipokalemijom ili hipomagnezemijom.
English: If parenteral benzodiazepines are essential for management of post injection adverse reactions, careful evaluation of clinical status for excessive sedation and cardiorespiratory depression is recommended (see section 4.5).
Croatian: Ako je u liječenju postinjekcijskih nuspojava nužna primjena parenteralnih pripravaka benzodiazepina, važno je pažljivo procijeniti klinički status bolesnika kako ne bi došlo do pretjerane sedacije i kardiorespiratorne depresije (vidjeti dio 4.5).
English: Post-injection syndrome reactions have occurred with ZYPADHERA leading to symptoms consistent with olanzapine overdose (see sections 4.2 and 4.4).
Croatian: Kod primjene lijeka ZYPADHERA nastupile su nuspojave postinjekcijskog sindroma koje dovode do simptoma poput onih koji se javljaju kod predoziranja olanzapinom (vidjeti dijelove 4.2 i 4.4).
English: In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson's disease, worsening of Parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo.
Croatian: U kliničkim ispitivanjima s bolesnicima s Parkinsonovom bolešću koji su razvili psihozu uslijed primjene lijekova (dopaminskih agonista), pogoršanje simptoma parkinsonizma i halucinacije prijavljene su vrlo često i učestalije nego kod ispitanika koji su dobivali placebo.
English: • If you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting (being sick) or usage of diuretics (water tablets)
Croatian: • bolujete od napadaja  ako znate da možda imate nedovoljno soli u organizmu kao posljedicu dugotrajnog teškog proljeva i povraćanja ili zbog uzimanja diuretika (tableta za izlučivanje vode iz organizma)
English: Most of these patients have developed symptoms of sedation (ranging from mild in severity up to coma) and/or delirium (including confusion, disorientation, agitation, anxiety and other cognitive impairment).
Croatian: Većina tih bolesnika razvila je simptome sedacije (različitih stupnjeva težine, od blage do teške sedacije, tj. kome) i/ili delirija (uključujući konfuziju, dezorijentaciju, agitaciju, anksioznost i druga oštećenja kognitivnih funkcija).
English: Metabolism and nutrition disorders Weight gain1
Croatian: Poremećaji metabolizma i prehrane porast tjelesne težine1
English: ZYPADHERA treatment groups of 150 mg and 300 mg given every 2 weeks (doses pooled for analysis) and 405 mg given every 4 weeks were non inferior to the combined doses of 10, 15 and 20 mg of oral olanzapine (doses pooled for analysis) as measured by rates of exacerbation of symptoms of schizophrenia (respective exacerbation rates, 10%, 10% 7%).
Croatian: Skupine koje su primale lijek ZYPADHERA od 150 mg i 300 mg svaka 2 tjedna (doze ujedinjene za analizu) i 405 mg svaka 4 tjedna nisu bile inferiorne u odnosu na skupine koje su primale kombinirane doze od 10, 15 i 20 mg oralnog olanzapina (doze ujedinjene za analizu), a mjereno na temelju stope egzacerbacije simptoma shizofrenije (stope egzacerbacije 10%, 10%, 7%).
English: hypotonia, tremor, somnolence, respiratory distress, or feeding disorder.
Croatian: somnolencija, respiratorni distres ili poremećaj uzimanja hrane.
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU LIJEKA
English: There was a 3-fold increase in CVAE in patients treated with oral olanzapine compared to patients treated with placebo (1.3% vs. 0.4%, respectively).
Croatian: Uočeno je trostruko povećanje cerebrovaskularnih događaja u bolesnika liječenih oralnim oblikom olanzapina u usporedbi s bolesnicima koji su primali placebo (1,3% naspram 0,4%).
English: ZYPADHERA is given in doses of 150 mg to 300 mg every 2 weeks or 300 mg to 405 mg every 4 weeks.
Croatian: ZYPADHERA se primjenjuje u dozama od 150 mg do 300 mg svaka 2 tjedna ili 300 mg do 405 mg svaka 4 tjedna.
English: Visitwise mean change from baseline to endpoint in PANSS Total score indicated that by Day 3, patients in the 300 mg/2 weeks and 405 mg/4 weeks treatment groups had statistically significantly greater reductions in PANSS Total score compared to placebo (-8.6, -8.2, and -5.2, respectively).
Croatian: Vidljive srednje vrijednosti promjene od početka do ishoda u ukupnoj PANSS ocjeni ukazuju da su kod posjete na 3. dan bolesnici u skupini koja je primala 300 mg svaka 2 tjedna i 405 mg svaka 4 tjedna imali statistički značajno veće sniženje ukupne PANSS ocjene u usporedbi s placebom (-8,6, -8,2 i -5,2).
English: Other common side effects (may affect up to 1 in 10 people) with ZYPADHERA include sleepiness and injection site pain.
Croatian: Druge česte nuspojave (mogu se javiti u najviše 1 na 10 osoba) s lijekom ZYPADHERA uključuju pospanost i bol na mjestu primjene.
English: Adverse reactions seen with olanzapine pamoate
Croatian: Nuspojave primijećene kod primjene olanzapin pamoata
English: For obese patients, the 50 mm needle is recommended for injection: If the 50 mm needle is to be used for injection, attach the 38 mm safety needle to the syringe to withdraw the required suspension volume.
Croatian: Za pretile bolesnike preporučuje se igla od 50 mm za injekciju: Ako se za injekciju upotrebljava igla od 50 mm, pričvrstite zaštićenu iglu od 38 mm na štrcaljku kako biste navukli potrebnu količinu suspenzije.
English: Attach the selected 50 mm or 38 mm safety needle to the syringe prior to injection.
Croatian: Pričvrstite odabranu zaštićenu iglu od 50 mm ili 38 mm na štrcaljku prije injiciranja.
English: • Stroke or “mini” stroke (temporary symptoms of stroke)
Croatian: • imali ste moždani udar ili “mali” moždani udar (prolazni simptomi moždanog udara)
English: Remove the needle, holding the vial upright to prevent any loss of solvent.
Croatian: Izvadite iglu držeći bočicu uspravno kako bi se spriječio gubitak otapala.
English: In postmarketing reports with olanzapine, the event of sudden cardiac death has been reported in patients with olanzapine.
Croatian: U izvješćima o olanzapinu nakon stavljanja lijeka u promet zabilježeni su slučajevi iznenadne srčane smrti u bolesnika liječenih olanzapinom.
English: Press the needle into the sheath using a one-handed technique.
Croatian: Pritisnite iglu u pokrov koristeći jednu ruku.
English: Driving and using machines Do not drive or operate machinery for the remainder of the day after each injection.
Croatian: Nemojte voziti niti upravljati strojevima ostatak dana nakon što ste primili injekciju.
English: For the remainder of the day after injection, patients should be advised to be vigilant for signs and symptoms of overdose secondary to post injection adverse reactions, be able to obtain assistance if needed and should not drive or operate machinery (see section 4.7).
Croatian: Bolesnika se mora savjetovati da ostatak dana nakon injekcije pripazi na eventualnu pojavu znakova i simptoma predoziranja kao mogućih nuspojava davanja injekcije kako bi bio u mogućnosti na vrijeme osigurati pomoć u slučaju potrebe te da ne smije upravljati vozilom niti raditi sa strojevima (vidjeti dio 4.7).
English: Clinical signs and symptoms included symptoms of sedation (ranging from mild in severity up to coma) and/or delirium (including confusion, disorientation, agitation, anxiety and other cognitive impairment).
Croatian: Klinički znakovi i simptomi uključuju simptome sedacije (različitih stupnjeva težine; od blage do teške sedacije, tj. kome) i/ili delirija (uključujući konfuziju, dezorijentaciju, agitaciju, anksioznost i druga oštećenja kognitivnih funkcija).
English: Very common adverse reactions associated with the use of olanzapine in this patient group were abnormal gait and falls.
Croatian: Vrlo česte nuspojave povezane s primjenom olanzapina u ovoj skupini bolesnika bile su poremećaj hodanja i padovi.
English: The most frequently (seen in ≥ 1% of patients ) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension,
Croatian: Najčešće prijavljivane nuspojave povezane s primjenom olanzapina u kliničkim ispitivanjima (uočene u ≥ 1% bolesnika) bile su: somnolencija, povećanje tjelesne težine, eozinofilija, povišena razina prolaktina, kolesterola, glukoze i triglicerida (vidjeti dio 4.4), glikozurija, pojačan tek, omaglica, akatizija, parkinsonizam, leukopenija, neutropenija (vidjeti dio 4.4), diskinezija, ortostatska hipotenzija, antikolinergički učinci, prolazna asimptomatska povišenja jetrenih aminotransferaza
English: No specific investigations have been conducted in the elderly with ZYPADHERA.
Croatian: Nisu provedena posebna ispitivanja primjene lijeka ZYPADHERA u starijih osoba.
English: After clinical reassessment dose may be adjusted within the range 150 mg to 300 mg every 2 weeks or 300 to 405 mg every 4 weeks.
Croatian: Nakon ponovne kliničke procjene dozu se može prilagođavati unutar raspona od 150 mg do 300 mg svaka dva tjedna ili od 300 do 405 mg svaka četiri tjedna (Tablica 1).
English: 2 Mean increases in fasting lipid values (total cholesterol, LDL cholesterol, and triglycerides) were greater in patients without evidence of lipid dysregulation at baseline.
Croatian: 2 Srednji porast vrijednosti lipida natašte (ukupni kolesterol, LDL kolesterol i trigliceridi) bio je veći u bolesnika u kojih na početku nije bilo znakova poremećaja lipida.
English: Patients were randomized to receive injections of ZYPADHERA 405 mg every 4 weeks, 300 mg every 2 weeks, 210 mg every 2 weeks, or placebo every 2 weeks.
Croatian: Bolesnici su randomizirani u skupine koje su primale injekcije lijeka ZYPADHERA od 405 mg svaka 4 tjedna, 300 mg svaka 2 tjedna, 210 mg svaka 2 tjedna ili placebo svaka 2 tjedna.
English: Parkinsonism6 Dyskinesia6
Croatian: Nepoznato somnolencija omaglica akatizija6 parkinsonizam6 diskinezija6
English: Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature; abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing severe stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white parts of the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or painful erection.
Croatian: Rijetke nuspojave (mogu se javiti u manje od 1 na 1000 osoba) uključuju snižavanje normalne tjelesne temperature; abnormalne srčane ritmove; iznenadnu neobjašnjivu smrt; upalu gušterače koja uzrokuje jaku bol u želucu, vrućicu i osjećaj mučnine; bolest jetre koja se javlja kao žuta boja kože i bijelih dijelova očiju (bjeloočnica); bolest mišića koja se javlja kao neobjašnjiva bolnost i bolovi; te produljene i/ili bolne erekcije.
English: Visually check the vial for clumps.
Croatian: Vizualno provjerite sadrži li suspenzija grudice.
English: The combination of the release profile and the dosage regimen (IM injection every two or four weeks) result in sustained olanzapine plasma concentrations.
Croatian: Kombinacijom profila oslobađanja i režima doziranja (intramuskularna injekcija svaka 2 ili 4 tjedna)
English: The combined 150 mg and 300 mg/2 week treatment group was non inferior to the 405 mg/4 week treatment group (exacerbation rates 10% for each group) at 24 weeks after randomisation.
Croatian: 150 mg i 300 mg svaka 2 tjedna nije bila inferiorna u odnosu na skupinu koja je primala 405 mg svaka 4 tjedna (stopa egzacerbacije u svakoj skupini bila je 10%) nakon 24 tjedna od randomizacije.
English: The most commonly reported injection site related adverse reaction was pain (5%); some other injection site adverse reactions reported were (in decreasing frequency): nodule type reactions, erythema type reactions, non-specific injection site reactions, irritation, oedema type reactions, bruising, haemorrhage, and anaesthesia.
Croatian: Najčešće prijavljena nuspojava na mjestu primjene injekcije bila je bol (5%); dok su druge nuspojave na mjestu primjene injekcije (redoslijedom prema manjoj učestalosti) bile: reakcije u obliku nodula, eritematozne reakcije, nespecifične reakcije na mjestu primjene injekcije, iritacija, edematozne reakcije, stvaranje modrica, krvarenje i anestezija.
English: Preclinical safety studies were performed using olanzapine pamoate monohydrate.
Croatian: Neklinička ispitivanja o sigurnosti primjene provedena su primjenom olanzapin pamoat hidrata.
English: Olanzapine administered with lithium or valproate resulted in increased levels (≥10%) of tremor, dry mouth, increased appetite, and weight gain.
Croatian: Davanje olanzapina s litijem ili valproatom rezultiralo je povećanom učestalošću (≥ 10%) tremora, suhoće usta,
English: Open the pre-packaged Hypodermic syringe and needle with needle protection device.
Croatian: Otvorite zajedničko pakiranje hipodermalne štrcaljke i igle sa zaštitnim pokrovom za iglu.
English: Table 1 Recommended dose scheme between oral olanzapine and ZYPADHERA Target oral olanzapine dose Recommended starting dose of ZYPADHERA
Croatian: Tablica 1 Shema preporučenog doziranja oralnog oblika olanzapina i lijeka ZYPADHERA
English: Increased alkaline phosphatase10
Croatian: povišena razina alkalne fosfataze10
English: • disorientation
Croatian: • dezorijentacija
English: INSTRUCTIONS FOR HEALTH CARE PROFESSIONALS
Croatian: UPUTE ZA ZDRAVSTVENE RADNIKE UPUTE ZA REKONSTITUCIJU
English: Tel: + 43 (0) 1 711 780
Croatian: m.b.H. Tel: + 43 (0) 1 711 780
English: Engage the needle safety device and remove needle from syringe.
Croatian: Namjestite zaštitni pokrov igle i uklonite iglu sa štrcaljke.
English: A small study of the effect of impaired liver function in 6 subjects with clinically significant (Childs Pugh Classification A (n = 5) and B (n = 1)) cirrhosis revealed little effect on the pharmacokinetics of orally administered olanzapine (2.5 - 7.5 mg single dose): Subjects with mild to moderate hepatic dysfunction had slightly increased systemic clearance and faster elimination half-time compared to subjects with no hepatic dysfunction (n = 3).
Croatian: Pugh A (n = 5) i B (n = 1)) cirozom, pokazalo je mali učinak na farmakokinetiku peroralno primijenjenog olanzapina (jedna doza od 2,5 - 7,5 mg): ispitanici s blagom do umjerenom disfunkcijom jetre imali su blago povišen sistemski klirens i brže poluvrijeme eliminacije u usporedbi s ispitanicima koji nisu imali disfunkciju jetre (n = 3).
English: Children and adolescents ZYPADHERA is not for patients who are under 18 years.
Croatian: ZYPADHERA nije namijenjena bolesnicima mlađima od 18 godina.
English: In clinical trials with oral olanzapine, clinically meaningful QTc prolongations (Fridericia QT correction [QTcF] ≥ 500 milliseconds [msec] at any time post baseline in patients with baseline QTcF<500 msec) were uncommon (0.1% to 1%) in patients treated with olanzapine, with no significant differences in associated cardiac events compared to placebo.
Croatian: (Fridericia QT korekcija [QTcF] ≥ 500 milisekundi [ms] u bilo kojem trenutku nakon početka liječenja u bolesnika koji su na početku liječenja olanzapinom imali vrijednost QTcF < 500 ms) bila su manje česta (0,1% do 1%) i bez značajnih razlika u povezanim srčanim događajima u usporedbi s placebom.
English: - Description of post injection syndrome - Recommendation for a 3-hour on-site observation period post injection - Recommendation for informing patients that for the remainder of the day of the injection, they should not drive or operate machinery, should be vigilant for signs and symptoms of a post injection syndrome event, and should be able to obtain assistance if needed - Description of the most common symptoms reported with olanzapine overdose that represent the clinical manifestation in post injection syndrome events - Recommendation for appropriate monitoring until the event resolves if an event should occur
Croatian: Opis postinjekcijskog sindroma - Preporuku za 3-satno razdoblje opservacije na mjestu davanja lijeka nakon injekcije - Preporuku o informiranju bolesnika da ostatak dana nakon injekcije ne bi trebali voziti ni upravljati strojevima, da bi trebali paziti na znakove i simptome postinjekcijskog sindroma te bi trebali moći pribaviti pomoć ako bude potrebno - Opis najučestalijih simptoma prijavljenih kod predoziranja olanzapinom koji predstavljaju kliničku manifestaciju događaja kod postinjekcijskog sindroma
English: Other adverse reactions observed in patients treated with ZYPADHERA were similar to those seen with oral olanzapine.
Croatian: Druge nuspojave uočene u bolesnika liječenih lijekom ZYPADHERA odgovarale su onima zabilježenima kod primjene oralnog oblika olanzapina.
English: Caution should be exercised in patients with low leukocyte and/or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of drug-induced bone marrow depression/toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease.
Croatian: Neutropenija Mora se s oprezom postupati u bolesnika koji iz bilo kojeg razloga imaju snižene vrijednosti leukocita i/ili neutrofila, zatim u bolesnika koji primaju lijekove za koje se zna da mogu prouzročiti neutropeniju, u bolesnika s anamnezom depresije/toksičnosti koštane srži uzrokovane lijekovima te u onih u kojih je do depresije koštane srži došlo uslijed istodobno prisutne bolesti, terapije zračenjem ili kemoterapije, kao i u bolesnika s hipereozinofilnim stanjima ili s mijeloproliferativnom bolešću.
English: Other symptoms noted include extrapyramidal symptoms, dysarthria, ataxia, aggression, dizziness, weakness, hypertension and convulsion.
Croatian: Od ostalih uočenih simptoma navode se ekstrapiramidni simptomi, dizartrija, ataksija, agresija, omaglica, slabost, hipertenzija i konvulzije.
English: In clinical trials with ZYPADHERA the incidence of injection site related adverse reactions was approximately 8%.
Croatian: Incidencija nuspojava na mjestu primjene injekcije u kliničkim ispitivanjima lijeka ZYPADHERA iznosila je približno 8%.
English: If the 38 mm needle is to be used for the injection, attach the 50 mm safety needle to withdraw the required suspension volume.
Croatian: Ako se za injekciju upotrebljava igla od 38 mm, Pričvrstite zaštićenu iglu od 50 mm na štrcaljku kako biste navukli potrebnu količinu suspenzije.
English: A total of 1469 patients with schizophrenia were included in 2 pivotal trials:
Croatian: U 2 pivotalna ispitivanja bilo je uključeno ukupno 1469 bolesnika sa shizofrenijom.
English: • excessive sleepiness
Croatian: • prekomjerna pospanost
English: Suspension concentration is 150 mg/ml olanzapine.
Croatian: Koncentracija suspenzije je 150 mg/ml olanzapina.
English: Pneumonia, increased body temperature, lethargy, erythema, visual hallucinations and urinary incontinence were observed commonly.
Croatian: letargija, eritem, vidne halucinacije i urinarna inkontinencija.
English: • muscle stiffness or shaking
Croatian: • ukočenost ili trzaji (drhtanje) mišića
English: ZYPADHERA is not recommended for treatment in the elderly population (65 years and over) unless a well-tolerated and effective dosage regimen using oral olanzapine has been established.
Croatian: Ne preporučuje se primjena lijeka ZYPADHERA u starijoj populaciji (65 godina i više), osim u bolesnika u kojih je uspostavljen učinkovit i dobro podnošljiv režim doziranja primjenom oralnog oblika olanzapina.
English: България ТП "Ели Лили Недерланд" Б.В.
Croatian: Eli Lilly Nederland B.V.
English: Very common: Weight gain13, elevated triglyceride levels14, increased appetite.
Croatian: Vrlo često: porast tjelesne težine13, povišene razine triglicerida14, pojačan tek Često: povišene razine kolesterola15
English: After insertion of the needle, aspirate for several seconds to ensure no blood appears.
Croatian: Aspirirajte nekoliko sekundi kako bi bili sigurni da nema pojave krvi nakon ulaska igle u mišić.
English: One Hypodermic syringe and safety needle.
Croatian: Jedna hipodermalna štrcaljka i zaštićena igla.